Alzamend Neuro Inc (ALZN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Alzamend Neuro Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.52x | -0.48x | -3.47x | -7.24x | -191.39x | -214.90x |
| P/B Ratio | 0.60x | -1.85x | 16.96x | 6.70x | 479.86x | 1153.33x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.58x | 0.14x | 2.03x | 12.37x | 3.24x | 1.83x |
| Quick Ratio | 6.58x | 0.14x | 2.03x | 12.37x | 3.26x | 1.83x |
| Leverage | ||||||
| Debt/Equity | 0.00x | -0.12x | 0.00x | 0.00x | 0.17x | 0.00x |
YoY = year-over-year change. Source: FMP..